NCT02058381
- Conditions
- PI3K Pathway Inhibition, Pre-menopausal Breast Cancer
- Locations
-
- Novartis Investigative Site Hong Kong
- Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea
- Novartis Investigative Site Gyeonggi-do, Korea, South Korea
- Novartis Investigative Site Seoul, Korea, South Korea